Dementia care is one of the critical issues facing the aged care industry. About 500,000 Australians currently live with the brain disorder condition, and this is tipped to rise to 1.1 million in a generation.
How to effectively provide quality care for people living with dementia was a key element of the royal commission into aged care, which found the complex care required was an ongoing challenge for the industry.
More than half the residents in aged care homes have a diagnosis of dementia. “We are deeply concerned that so many aged care providers do not seem to have the skills and capacity required to care adequately for people living with dementia,” the final report said.
To address these skills gaps, Dementia Australia, developed two applications to help with the learning and development of carers. Australian Health Journal spoke with Dr Tanya Petrovich, Dementia Australia’s Business Innovation Manager on how these platforms help those caring for people with dementia to understand, and improve their communication with people experiencing dementia. Tanya also spoke about last year Dementia Australia winning two Future of Ageing Awards in the Dementia Care and Business Technology categories.
Winner of Dementia Care category in the 2022 Future of Ageing Awards: Talk with Ted
The Talk With Ted program, created by Dementia Australia, simulates a typical chat including emotional and verbal responses between a carer and the resident.
“This type of experiential learning, that is both engaging and innovative, helps people to recall exactly what they’ve learned and makes them more likely to implement these new skills – which means better care for our loved ones living with dementia,” said Dementia Australia’s CEO Maree McCabe at the time of the launch.
The AI platform was created through a collaboration between Dementia Australia’s Centre for Dementia Learning and Deakin University’s Applied Artificial Intelligence Institute (A²I²), care workers, and was informed by real-life experiences of people living with dementia. Funding came from the Rosemary Norman Foundation.
Winner of Business Technology category in the 2022 Future of Ageing Awards: Ask Annie
There are more than 130,000 people working in-home support and community care across Australia. These people play a vital role for people living with dementia, their families, and carers.
‘Ask Annie’ is a virtual tool for community care workers providing dementia care in the home. Annie guides users through a range of scenarios, based on real-life experiences, to strengthen their dementia care skills.
The mobile app offers short, self-paced learning modules to help care workers refresh their skills and learn tips and tools to provide better care to people living with dementia. These are referred to as micro-learning training, that is accessible whenever a care worker wants to schedule a quick 10 or 15-minute lesson.
Ask Annie was developed by Dementia Australia with Deakin University’s Applied Artificial Intelligence Institute (A²I²), with the financial support of Gandel Philanthropy.
Produced with kind assistance from Inside Ageing and Future of Ageing Awards.
-
Study reveals socioeconomic barriers to children’s healthcare access
Research published in the Australian Journal of General Practice (AJGP) has revealed mental health and developmental–behavioural issues such as ADHD are the most common paediatric referrals in metropolitan general practices.
But the research also revealed children at higher risk are less likely to get the care they may need.
-
Continuity of Care under COVID-19
Series 3, Episode 1
Under the COVID-19 pandemic, the Australian Healthcare system has handled the public health crisis by monitoring and responding to challenges in supply chains, testing & tracing of new infections and stock piling of essential equipment.
The public has largely responded by practising social distancing, understanding how hand hygiene can spread contagion and recently installing the COVIDSafe mobile application. Public health messaging has been largely effective and literacy improve, to combat the dangers of misinformation.
To open up access to medical advice during the pandemic, in March the Australian government issued MBS item codes for telehealth consultations, for advanced practice nurses as well as GPs and other specialists.
According to AMA President Dr Tony Bartone, as of mid-May 2020, around 10 million Medicare-funded telehealth services have been provided, either over the phone or via video, a significant majority of which have been provided by GPs and other specialists since the Medicare telehealth items were introduced in March.
However in recent months, the health system has mounting concerns on:
- a reduction in general practice visits for testing, investigation or immunisation
- lower rates of elective procedures resuming since being halted
- reduction in laboratory testing
- reduction in treatments and diagnosis of chronic and acute conditions
- access to, and continuing to take medications
Those with pre-existing conditions have been urged to keep appointments and routine treatments to maintain their health.
Industry has taken action such as the newly formed Continuity of Care Collaboration (CCC). The 15 health organisations forming CCC are an Australian first national communication collaboration of Peak Bodies, Industry and Healthcare Organisations coming together to stress the importance for people to continue monitoring their health and maintaining their regular care.
This Australian Health Journal episode on the continuity of care was produced with commentary from the following health industry associations and organisations: APNA – Australian Primary Health Care Nurses Association, RACGP, Medical Technology Association of Australia (MTAA), West Cessnock Medical Practice, Consumers Health Forum of Australia, Medicines Australia
-
Taiwanese health and research delegation visit Paratus clinical trial site in Canberra
In late August 2025, a Taiwanese delegation comprising government officials from the Taiwanese FDA, various governmental groups, and physicians and researchers from across Taiwan, visited Paratus Clinical’s trial site in Canberra. Their objective was to explore both the differences and similarities between the clinical research ecosystems of Taiwan and Australia.
